A prospective, blinded, randomized, multicenter study to evaluate the utility, safety, and efficacy of using PEER Interactive

The process of selecting medications for patients suffering from behavioural disorders can be extremely challenging. The Psychiatric EEG Evaluation Registry (PEER) is a new and patented process that informs the physician in determining individualized treatment for each patient. The aim of this study is to improve the prescription accuracy of psychotropic medications for military personnel diagnosed with neuropsychiatric disorders and related conditions.

Age range

18-65 years old


Male and Female

Individuals are eligible if they

  • Are 18 – 65 years of age at screening;
  • Have a primary diagnosis of a depressive disorder.  Patients may have comorbidity of any non-psychotic disorder, as well as PTSD and/or mTBI;
  • Are able to safely withdraw from medications in order to have an unmedicated EEG

Individuals are not eligible if they

  • Have a diagnosis of a psychotic disorder;
  • Have a history of open head brain trauma, craniotomy, cerebral metastases, cerebrovascular accident, schizophrenia, schizo-affective disorder, dementia, mental retardation, or major depression with psychotic features;
  • Used depot neuroleptics in last 12 months;
  • Have a known pregnancy, lactation, or intend to become pregnant during this study.


The Royal's Operation Stress Injury (OSI) Clinic 
1145 Carling Ave, Ottawa, ON

Recruitment Via

  • Self-Referral (by participant)
  • Internal Referral (by OSI clinician)

Principal Investigator 

Verner Knott, PhD, C.Psych.


Amelie Vezina
+1 (613) 722-6521 ext. 6254
amelie.vezina@theroyal.ca OR Your OSI Clinician

*This study is actively recruiting participants